CLINICAL_TRIALS
trial_result
· 2019-02-15
Clinical Trial Update: Study of LY2835219 for Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 clinical trial update for LY2835219 in mantle cell lymphoma has completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2019-02-15